Tech Company Financing Transactions
SynCardia Systems Funding Round
SynCardia Systems secured a $14 million funding round on 12/17/2013. Investors included Athyrium Opportunities Fund and private investors.
Transaction Overview
Company Name
Announced On
12/17/2013
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Investors
Athyrium Opportunities Fund (Laurent Hermouet)
Proceeds Purpose
The new financing allows SynCardia to accelerate the development and launch of its 50cc Total Artificial Heart* through an FDA-approved clinical study. The funds also will help the company meet the increasing demand for the Freedom portable drivers.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1992 East Silverlake Road
Tucson, AZ 85713
USA
Tucson, AZ 85713
USA
Phone
Website
Email Address
Overview
SynCardia Systems, Inc. is the manufacturer of the CardioWest temporary Total Artificial Heart (TAH-t). It is the only FDA and CE approved temporary Total Artificial Heart in the world. It is designed for severely ill patients with end-stage biventricular failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Garippa
Chief Financial Officer
Dan Hudspeth
Chief Operating Officer
Douglas Nutter
Browse more venture capital transactions:
Prev: 12/17/2013: PadInMotion venture capital transaction
Next: 12/17/2013: Nanotronics Imaging venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs